Free Trial

Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Grows By 125.0%

Sysmex logo with Medical background

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 900 shares, an increase of 125.0% from the December 31st total of 400 shares. Based on an average daily volume of 216,100 shares, the short-interest ratio is presently 0.0 days.

Sysmex Trading Down 2.1 %

OTCMKTS SSMXY traded down $0.41 on Friday, reaching $19.07. The company had a trading volume of 85,748 shares, compared to its average volume of 84,389. Sysmex has a 52 week low of $14.38 and a 52 week high of $28.58. The stock's 50 day moving average is $19.25 and its 200-day moving average is $18.89. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The stock has a market cap of $12.00 billion, a price-to-earnings ratio of 38.45 and a beta of 0.89.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.16 earnings per share (EPS) for the quarter. The firm had revenue of $877.31 million for the quarter. Equities analysts predict that Sysmex will post 0.57 earnings per share for the current year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Featured Stories

Should You Invest $1,000 in Sysmex Right Now?

Before you consider Sysmex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.

While Sysmex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines